Covid Inquiry: Abuse of experts must stop, says Whitty
Sir Chris laments treatment as he gives evidence to Covid Inquiry on pandemic preparedness.
Similar Posts
Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug | Reuters News Agency
Health 25 August 2023, 6:39 pm 1 minute Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but…
Microplastics found in overwhelming majority of American meat, water, plants: study
A new study has found that the overwhelming majority of protein foods such as meat and fish are contaminated with microplastics. The comprehensive study, conducted by researchers at the nonprofit Ocean Conservancy, found that approximately 88% of protein samples tested contained microplastic particles. “Highly processed products contained the most microplastics per gram,” the study said…
Junior doctors’ strike: NHS chief warns of tough new year
A planned six-day junior doctors’ strike will have a big impact on routine care, a health chief says.
FDA issues warning about fake Ozempic
FDA issues warning about fake Ozempic – CBS News Watch CBS News The Food and Drug Administration reports that it has seized thousands of units of counterfeit Ozempic, the popular diabetes medication that is also used for weight loss. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting….
New COVID variant JN.1 now comprises up to 30% of US cases: CDC
The latest variant of the COVID-19 virus, JN.1, is now responsible for an estimated 15% to 29% of cases in the U.S. as of Dec. 8, according to a posted update from the Centers for Disease Control and Prevention (CDC). JN.1, which is currently the country’s fastest growing variant, is expected to continue to increase…
Asia’s year in review: Who had it good — and who had it bad — in 2023
Curtis S. Chin, a former U.S. ambassador to the Asian Development Bank, is managing director of advisory firm RiverPeak Group. Jose B. Collazo is an analyst focusing on the Indo-Pacific region. Follow them on X at @CurtisSChin and @JoseBCollazo. As 2023 comes to a close, we take a look at the year that was in…
